Euclid Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-137,350
| Closed | -$11.5M | – | 197 |
|
|
2016
Q2 | $11.5M | Sell |
137,350
-7,745
| -5% | -$646K | 0.5% | 55 |
|
|
2016
Q1 | $13.3M | Sell |
145,095
-76,697
| -35% | -$7.05M | 0.5% | 52 |
|
|
2015
Q4 | $22.4M | Buy |
221,792
+129,792
| +141% | +$13.1M | 0.69% | 32 |
|
|
2015
Q3 | $9.03M | Sell |
92,000
-248,745
| -73% | -$24.4M | 0.41% | 85 |
|
|
2015
Q2 | $39.9M | Sell |
340,745
-313,825
| -48% | -$36.7M | 0.79% | 32 |
|
|
2015
Q1 | $64.2M | Buy |
+654,570
| New | +$64.2M | 1.18% | 14 |
|
|
2014
Q4 | – | Sell |
-769,310
| Closed | -$81.9M | – | 428 |
|
|
2014
Q3 | $81.9M | Buy |
769,310
+39,930
| +5% | +$4.25M | 0.59% | 28 |
|
|
2014
Q2 | $60.5M | Sell |
729,380
-288,652
| -28% | -$23.9M | 0.42% | 43 |
|
|
2014
Q1 | $72.1M | Buy |
1,018,032
+240,700
| +31% | +$17.1M | 0.54% | 35 |
|
|
2013
Q4 | $58.4M | Sell |
777,332
-43,020
| -5% | -$3.23M | 0.48% | 39 |
|
|
2013
Q3 | $51.6M | Buy |
820,352
+55,992
| +7% | +$3.52M | 0.52% | 39 |
|
|
2013
Q2 | $39.1M | Buy |
+764,360
| New | +$39.1M | 0.49% | 43 |
|